When reviewing the database with NAD + precursors as interventions yet with the other term input using aging , it indicates that there are currently no ongoing or published clinical trials for NA, 2 trials exploring NAM, 4 trials examining NAD + , 5 trials investigating NMN, and 18 trials focused on NR in elderly cohorts
PlexusDx does not sell other GLP-1 category compounds such as retatrutide, which is investigational and not FDA-approved
If youre dealing with frequent infections, poor immunity, or chronic inflammatory symptoms, Book your Root Cause Analysis to understand what your body may actually be missing before turning to supplements or peptide therapies
It's not a magic bullet, but it may offer layered support for those seeking consistency, resilience, and accelerated return-to-training timelines